Eucrisa Ointment
Product Images NDC 55724-211

9 FDA label images from Pfizer Laboratories Div Pfizer Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Eucrisa (NDC 55724-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Eucrisa 01)

Chemical Structure (Eucrisa 01)
Chemical structure of crisaborole showing its molecular framework including boron-oxygen and cyano functional groups.*
FDA Label Image

Figure 1 (Eucrisa 02)

Figure 1 (Eucrisa 02)
A line graph comparing the percentage of subjects with success in ISGA over 29 days for Eucrisa Ointment 20 mg/g and a vehicle ointment. The vertical axis shows percentage success, and the horizontal axis shows days (1, 8, 15, 22, 29). Eucrisa ointment shows higher success rates at all measured time points compared to vehicle ointment.*
FDA Label Image

Figure 1 (Eucrisa 03)

Figure 1 (Eucrisa 03)
A line graph comparing the percentage of subjects with success in ISGA over 29 days between Eucrisa ointment and vehicle ointment. The graph shows data points at days 1, 8, 15, 22, and 29, with Eucrisa ointment consistently achieving higher success rates than the vehicle ointment.*
FDA Label Image

Logo (Eucrisa 04)

FDA Label Image

Logo (Eucrisa 05)

FDA Label Image

Principal Display Panel (60 g Tube Label)

Principal Display Panel (60 g Tube Label)
Eucrisa (crisaborole) ointment 2% topical ointment label, 60 g size, distributed by Pfizer Laboratories Div Pfizer Inc. The label indicates prescription-only status and usage instructions, including storage conditions and application directions. The product strength is 2% crisaborole in ointment form.*
FDA Label Image

Principal Display Panel (60 g Tube Carton)

Principal Display Panel (60 g Tube Carton)
Packaging label for Eucrisa (crisaborole) ointment 2%, a topical prescription drug. The label shows the product name, strength (2%), and dosage form (ointment) along with usage instructions indicating topical use only. The package contains 60 g of ointment and is distributed by Pfizer Labs, division of Pfizer Inc. The label includes storage instructions and a barcode.*
FDA Label Image

Principal Display Panel (60 g Tube Label)

Principal Display Panel (60 g Tube Label)
The Eucrisa (crisaborole) ointment 2% packaging label displays the product name and strength prominently. It is a 60 g tube of prescription topical ointment for external use only, distributed by Pfizer Laboratories Div Pfizer Inc. The label includes storage instructions, usage warnings, and a note that it is a professional sample not for sale.*
FDA Label Image

Principal Display Panel (60 g Tube Carton)

Principal Display Panel (60 g Tube Carton)
The image shows the flat carton packaging for Eucrisa (crisaborole) ointment 2%. The label states it is a 60 g tube for topical use only, not for ophthalmic, oral, or intravaginal use. It is a professional sample, not for sale. Distributed by Pfizer Laboratories, Division of Pfizer Inc, NY. Storage and dosage instructions are included, specifying 20 mg/g strength and application twice daily.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.